{"id":"https://openalex.org/W1977191981","doi":"https://doi.org/10.1037/1064-1297.5.3.183","title":"Benzodiazepine-GABA modulation of concurrent ethanol and sucrose reinforcement in the rat.","display_name":"Benzodiazepine-GABA modulation of concurrent ethanol and sucrose reinforcement in the rat.","alternate_titles":[],"publication_year":1997,"publication_date":"1997-08-01","ids":{"openalex":"https://openalex.org/W1977191981","doi":"https://doi.org/10.1037/1064-1297.5.3.183","mag":"1977191981","pmid":"https://pubmed.ncbi.nlm.nih.gov/9260066"},"language":"en","primary_location":{"id":"doi:10.1037/1064-1297.5.3.183","doi":"https://doi.org/10.1037/1064-1297.5.3.183","is_oa":false,"landing_page_url":"https://doi.org/10.1037/1064-1297.5.3.183","pdf_url":null,"source":{"id":"https://openalex.org/S357931","display_name":"Experimental and Clinical Psychopharmacology","issn_l":"1064-1297","issn":["1064-1297","1936-2293"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320262","host_organization_name":"American Psychological Association","host_organization_lineage":["https://openalex.org/P4310320262"],"host_organization_lineage_names":["American Psychological Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental and Clinical Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1977191981"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085905942","display_name":"Nancy M. Petry","orcid":"https://orcid.org/0000-0003-2462-1752","observed_orcids":["https://orcid.org/0000-0003-2462-1752"]},"institutions":[{"id":"https://openalex.org/I140172145","display_name":"University of Connecticut","ror":"https://ror.org/02der9h97","country_code":"US","type":"education","lineage":["https://openalex.org/I140172145"]},{"id":"https://openalex.org/I75929689","display_name":"UConn Health","ror":"https://ror.org/02kzs4y22","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I75929689"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Nancy M. Petry","raw_affiliation_strings":["U Connecticut, School of Medicine, Dept of Psychiatry, Farmington, CT, US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"U Connecticut, School of Medicine, Dept of Psychiatry, Farmington, CT, US","institution_ids":["https://openalex.org/I140172145","https://openalex.org/I75929689"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5085905942"],"corresponding_institution_ids":["https://openalex.org/I140172145","https://openalex.org/I75929689"],"apc_list":null,"apc_paid":null,"fwci":0.2233,"has_fulltext":false,"cited_by_count":70,"citation_normalized_percentile":{"value":0.39562526,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"5","issue":"3","first_page":"183","last_page":"194"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.524399995803833,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.524399995803833,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.4603999853134155,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.003800000064074993,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ethanol-intake","display_name":"ethanol consumption","score":0.7570000290870667},{"id":"https://openalex.org/keywords/sucrose-reinforcement","display_name":"sucrose reinforcement","score":0.9150000214576721},{"id":"https://openalex.org/keywords/concurrent-reinforcement","display_name":"concurrent reinforcement","score":0.7910000085830688},{"id":"https://openalex.org/keywords/ro-15-4513","display_name":"Ro 15-4513","score":0.9070000052452087},{"id":"https://openalex.org/keywords/ro-15-1788","display_name":"Ro 15-1788","score":0.984000027179718},{"id":"https://openalex.org/keywords/chlordiazepoxide","display_name":"chlordiazepoxide","score":0.9869999885559082},{"id":"https://openalex.org/keywords/baclofen","display_name":"baclofen","score":0.890999972820282},{"id":"https://openalex.org/keywords/picrotoxin","display_name":"picrotoxin","score":0.9869999885559082},{"id":"https://openalex.org/keywords/muscimol","display_name":"muscimol","score":0.9990000128746033},{"id":"https://openalex.org/keywords/inverse-agonists","display_name":"inverse agonists","score":0.7379999756813049},{"id":"https://openalex.org/keywords/agonists","display_name":"agonists","score":0.6019999980926514},{"id":"https://openalex.org/keywords/ethanol-preference","display_name":"ethanol preference","score":0.32199999690055847}],"concepts":[{"id":"https://openalex.org/C2778325228","wikidata":"https://www.wikidata.org/wiki/Q178566","display_name":"Chlordiazepoxide","level":3,"score":0.858095109462738},{"id":"https://openalex.org/C2779188335","wikidata":"https://www.wikidata.org/wiki/Q412504","display_name":"Muscimol","level":4,"score":0.767236590385437},{"id":"https://openalex.org/C2779324764","wikidata":"https://www.wikidata.org/wiki/Q416602","display_name":"Picrotoxin","level":4,"score":0.7224102020263672},{"id":"https://openalex.org/C2781201050","wikidata":"https://www.wikidata.org/wiki/Q413717","display_name":"Baclofen","level":4,"score":0.6760110855102539},{"id":"https://openalex.org/C89951826","wikidata":"https://www.wikidata.org/wiki/Q1671731","display_name":"Inverse agonist","level":4,"score":0.675154983997345},{"id":"https://openalex.org/C2780161600","wikidata":"https://www.wikidata.org/wiki/Q153","display_name":"Ethanol","level":2,"score":0.6587136387825012},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.6393992900848389},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6241888403892517},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5525052547454834},{"id":"https://openalex.org/C168258287","wikidata":"https://www.wikidata.org/wiki/Q60147","display_name":"GABAA receptor","level":3,"score":0.5243411660194397},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5045706033706665},{"id":"https://openalex.org/C2778597767","wikidata":"https://www.wikidata.org/wiki/Q4027534","display_name":"Sucrose","level":2,"score":0.4945845305919647},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.4715079367160797},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.46001195907592773},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3928828835487366},{"id":"https://openalex.org/C2776175493","wikidata":"https://www.wikidata.org/wiki/Q210402","display_name":"Diazepam","level":2,"score":0.2592393457889557},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2240522801876068},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.21256175637245178},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18523326516151428}],"mesh":[{"descriptor_ui":"D000428","descriptor_name":"Alcohol Drinking","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D000431","descriptor_name":"Ethanol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002492","descriptor_name":"Central Nervous System Depressants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003216","descriptor_name":"Conditioning, Operant","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011963","descriptor_name":"Receptors, GABA-A","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D012054","descriptor_name":"Reinforcement, Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013395","descriptor_name":"Sucrose","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058785","descriptor_name":"GABA-A Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058787","descriptor_name":"GABA-A Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1037/1064-1297.5.3.183","doi":"https://doi.org/10.1037/1064-1297.5.3.183","is_oa":false,"landing_page_url":"https://doi.org/10.1037/1064-1297.5.3.183","pdf_url":null,"source":{"id":"https://openalex.org/S357931","display_name":"Experimental and Clinical Psychopharmacology","issn_l":"1064-1297","issn":["1064-1297","1936-2293"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320262","host_organization_name":"American Psychological Association","host_organization_lineage":["https://openalex.org/P4310320262"],"host_organization_lineage_names":["American Psychological Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental and Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"doi:10.1037//1064-1297.5.3.183","doi":"https://doi.org/10.1037//1064-1297.5.3.183","is_oa":false,"landing_page_url":"https://doi.org/10.1037//1064-1297.5.3.183","pdf_url":null,"source":{"id":"https://openalex.org/S357931","display_name":"Experimental and Clinical Psychopharmacology","issn_l":"1064-1297","issn":["1064-1297","1936-2293"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320262","host_organization_name":"American Psychological Association","host_organization_lineage":["https://openalex.org/P4310320262"],"host_organization_lineage_names":["American Psychological Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental and Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:9260066","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9260066","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental and clinical psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.7246000170707703}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4413147244","display_name":"Etiology and Treatment of Alcohol Dependence","funder_award_id":"P50AA003510","funder_id":"https://openalex.org/F4320337330","funder_display_name":"National Institute on Alcohol Abuse and Alcoholism"},{"id":"https://openalex.org/G6013066457","display_name":"MAINTENANCE AND DEVELOPMENT OF NEED FOR ALCOHOL","funder_award_id":"R03AA008731","funder_id":"https://openalex.org/F4320337330","funder_display_name":"National Institute on Alcohol Abuse and Alcoholism"}],"funders":[{"id":"https://openalex.org/F4320337330","display_name":"National Institute on Alcohol Abuse and Alcoholism","ror":"https://ror.org/02jzrsm59"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":65,"referenced_works":["https://openalex.org/W598879506","https://openalex.org/W612904245","https://openalex.org/W1589728983","https://openalex.org/W1594727599","https://openalex.org/W1900549838","https://openalex.org/W1934123101","https://openalex.org/W1963512037","https://openalex.org/W1966436616","https://openalex.org/W1967236505","https://openalex.org/W1968503840","https://openalex.org/W1968952536","https://openalex.org/W1971547902","https://openalex.org/W1972056987","https://openalex.org/W1972191901","https://openalex.org/W1976130361","https://openalex.org/W1976348580","https://openalex.org/W1976759880","https://openalex.org/W1976870151","https://openalex.org/W1978408777","https://openalex.org/W1982101586","https://openalex.org/W1984849674","https://openalex.org/W1993202660","https://openalex.org/W2000120332","https://openalex.org/W2001303662","https://openalex.org/W2001315015","https://openalex.org/W2005146693","https://openalex.org/W2006088829","https://openalex.org/W2009712351","https://openalex.org/W2010822917","https://openalex.org/W2016333855","https://openalex.org/W2018827261","https://openalex.org/W2019823389","https://openalex.org/W2020329681","https://openalex.org/W2022650028","https://openalex.org/W2023935196","https://openalex.org/W2026028975","https://openalex.org/W2028650350","https://openalex.org/W2035974852","https://openalex.org/W2041364994","https://openalex.org/W2048158880","https://openalex.org/W2049512449","https://openalex.org/W2056473181","https://openalex.org/W2057910028","https://openalex.org/W2059282872","https://openalex.org/W2059962646","https://openalex.org/W2063917923","https://openalex.org/W2064119146","https://openalex.org/W2078467443","https://openalex.org/W2086464244","https://openalex.org/W2087716652","https://openalex.org/W2092733380","https://openalex.org/W2116522149","https://openalex.org/W2121603624","https://openalex.org/W2129553731","https://openalex.org/W2131216096","https://openalex.org/W2133817858","https://openalex.org/W2136480178","https://openalex.org/W2141045574","https://openalex.org/W2141741104","https://openalex.org/W2144456014","https://openalex.org/W2160628975","https://openalex.org/W2162925069","https://openalex.org/W2261791402","https://openalex.org/W2507030560","https://openalex.org/W3024499496"],"related_works":["https://openalex.org/W2086679927","https://openalex.org/W2025167609","https://openalex.org/W1967236505","https://openalex.org/W2043307419","https://openalex.org/W2059651110","https://openalex.org/W2019735414","https://openalex.org/W2018167859","https://openalex.org/W1968952536","https://openalex.org/W2004439638","https://openalex.org/W2265844598"],"abstract_inverted_index":{"These":[0,162],"experiments":[1],"examined":[2],"the":[3,6,93,102,116,124,133,159,169,172],"role":[4],"of":[5,41,64,73,115,132,140,150,168],"benzodiazepine":[7],"(BZ)-GABA":[8],"receptor":[9,174],"complex":[10,175],"in":[11,15,81,166],"modulating":[12],"ethanol":[13,61,94,125,160,177],"consumption":[14,149],"rats.":[16],"Lever":[17],"presses":[18],"were":[19,34],"reinforced":[20],"with":[21,83],"concurrently":[22],"available,":[23],"isocaloric":[24],"solutions:":[25],"10%":[26],"ethanol-10%":[27],"sucrose":[28,50,146],"and":[29,52,78,89,98,108,147,153,176],"24%":[30],"sucrose.":[31],"Both":[32],"reinforcers":[33,51],"available":[35],"on":[36],"independent,":[37],"variable-interval":[38],"5-s":[39],"schedules":[40],"reinforcement.":[42],"In":[43],"baseline":[44],"sessions,":[45,69],"rats":[46,70],"earned":[47],"approximately":[48],"110":[49],"131":[53],"ethanol-sucrose":[54],"reinforcers,":[55],"equivalent":[56],"to":[57],"about":[58],"2":[59],"g":[60],"per":[62],"kilogram":[63],"body":[65],"weight.":[66],"Before":[67],"experimental":[68],"received":[71],"injections":[72],"Ro":[74,76,79,84,106,119],"15-4513,":[75,85,107],"15-1788,":[77],"15-4513":[80],"combination":[82],"chlordiazepoxide,":[86],"picrotoxin,":[87],"baclofen,":[88],"muscimol.":[90],"Responding":[91],"for":[92,123,145,158],"solution":[95,126],"was":[96,111],"significantly":[97,142],"selectively":[99,155],"reduced":[100,156],"by":[101,113],"BZ":[103,117,134],"inverse":[104],"agonist":[105,135],"this":[109],"effect":[110],"blocked":[112],"administration":[114],"antagonist":[118],"15-1788.":[120],"Conversely,":[121],"responding":[122,144,157],"increased":[127,148],"following":[128],"a":[129],"low":[130,138],"dose":[131,139],"chlordiazepoxide.":[136],"A":[137],"baclofen":[141],"decreased":[143],"ethanol.":[151],"Picrotoxin":[152],"muscimol":[154],"solution.":[161],"results":[163],"are":[164],"discussed":[165],"terms":[167],"relationship":[170],"between":[171],"BZ-GABA":[173],"consumption.":[178]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1977191981","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
